Biotron Healthcare (India) Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 5.00 M
as on 17-07-2024
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.50 M
as on 17-07-2024
- Satisfied Charges ₹ 149.61 M
as on 17-07-2024
- Revenue 42.59%
(FY 2023)
- Profit 607.37%
(FY 2023)
- Ebitda 106.34%
(FY 2023)
- Net Worth 23.95%
(FY 2023)
- Total Assets 1.44%
(FY 2023)
About Biotron Healthcare (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.65 Cr. The company has closed loans amounting to ₹14.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shrikanth Hangal, Venkatesh Voleti, and Gayathri Ranganathan serve as directors at the Company.
- CIN/LLPIN
U33100MH1998PTC116175
- Company No.
116175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 1998
- Date of AGM
31 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Chembur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biotron Healthcare (India) Private Limited offer?
Biotron Healthcare (India) Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, PCR Machine, Extraction Plants and Extruders, Extraction Machinery.
Who are the key members and board of directors at Biotron Healthcare (India)?
Board Members(3)
Financial Performance and Corporate Structure Insights of Biotron Healthcare (India).
Biotron Healthcare (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.59% increase. The company also saw a substantial improvement in profitability, with a 607.37% increase in profit. The company's net worth Soared by an impressive increase of 23.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotron Healthcare (India)?
In 2022, Biotron Healthcare (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biotron Biotech Private Limited
Active
12 years 8 months Shrikanth Hangal, Venkatesh Voleti and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2018 | ₹2.65 Cr | Open |
Yes Bank Limited Creation Date: 08 Aug 2012 | ₹3.70 Cr | Satisfied |
Yes Bank Limited Creation Date: 06 Jul 2012 | ₹3.61 Cr | Satisfied |
How Many Employees Work at Biotron Healthcare (India)?
Unlock and access historical data on people associated with Biotron Healthcare (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jul 06, 2010, Biotron Healthcare (India) has raised a total of ₹ 2.58 M, with the most recent deal valued at ₹ 0.7 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
